Advertisement
Advertisement

RIGL

RIGL logo

Rigel Pharmaceuticals Inc. (New)

21.06
USD
+0.06
+0.28%
Jul 31, 15:59 UTC -4
Closed
exchange

Pre-Market

20.03

-1.03
-4.91%

Rigel Pharmaceuticals Inc. (New) Profile

Info & Links

CEO

Raul R. Rodriguez

Headquarters

611 GATEWAY BOULEVARD, SUITE 900
SOUTH SAN FRANCISCO, CA 94080, UNITED STATES

Sector

Medical

Auditor

Ernst & Young LLP

Share holders

28

Employees

164

Rigel Pharmaceuticals Inc. (New) Statistics

Valuation Measures

Market Capitalization2

357.91M

Enterprise Value

371.93M

Enterprise Value/EBITDA(ttm)

8.14

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

--

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

89.89%

Operating Margin(ttm)

--

Profit Margin(ttm)

16.51%

Return on Equity(ttm)

--

Return on Invested Capital(ttm)

67.84%

Return on Assets(ttm)

--

Income Statement

Revenue(ttm)

203.08M

Revenue Per Share(ttm)

11.36

Gross Profit(ttm)

182.05M

EBITDA(ttm)3

45.67M

Net Income Available to Common(ttm)

37.18M

Diluted EPS(ttm)

--

Share Statistics

Beta (5Y Monthly)

--

52-Week Change

99.05%

S&P 500 52-Week Change

16.39%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

17.87M

Dividend Yield

--

Float4

--

% Held by Insiders

--

% Held by Institutions

--

Balance Sheet

Total Cash(mrq)

77.10M

Total Cash Per Share(mrq)

4.31

Total Debt(mrq)

59.75M

Total Debt/Equity(mrq)

321.79%

Current Ratio(mrq)

2.20%

Quick Ratio(mrq)

--

Book Value Per Share(mrq)

1.04

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.05

Free Cash Flow(ytd)

-893.00K

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement